南加大醫療決策分析碩士項目宣講會
時間：12月3日周一中午12:30
地點：tyc1286太陽集團邯鄲校區馬錦明樓109室
*該宣講會需要提前注冊http://uscshanghai.mikecrm.com/UKcNZF7 歡迎參加
Master of Science in Healthcare Decision Analysis
Program Overview:
TheMaster of Science in Healthcare Decision Analysis (HCDA) is a unique, interdisciplinary program designed to prepare graduates seeking to improve their business and analytical abilities to enter careers in the healthcare sector related to product value and pricing, international access and reimbursement, and competitive business intelligence. HCDA follows a strategic approach to learning and focuses on the intersection of health economics, global coverage and health delivery, and applied international health policy. The program provides an opportunity for students to be at the forefront of a field in which current insurers, the pharmaceutical industry, healthcare systems and consulting firms cannot find enough qualified individuals to meet demand.
Program Highlights:
Concentrated 1 weekends per-semester schedule ideal for working professionals
Adult education learning emphasizing case au dies, team projects, war games
Coursework suitable for most business, science, economic and industry professionals
No course prerequisites or pre-set order of classes
Flexible distance and classroom learning including 'on-demand' lectures
Top 10 nationally ranked USC School of Pharmacy, No. 1 ranked private pharmacy school
Areas of Specialization:
Biopharmaceutical Marketing
Business Intelligence
Health Economics
Managed Care
Policy Analysis
Pricing
Value, Access, and Reimbursement
Course Structure:
The HCDA program is structured for easy access to both full-time and part-time students, and to allow each of them to progress at their own pace. The completion of eleven courses totaling 33 units is a requirement for graduation. No thesis is required.
For more information, go to https://hcda.usc.edu/
Speaker Profiles:
Mr. Grant Lawless, RPh, MD
Program Director of M.S. in Healthcare Decision Analysis (HCDA) and M.S. in Biopharmaceutical Marketing (BPMK)
Associate Professor of Pharmaceutical and Health Economics, USC School of Pharmacy
Ms. Michelle Ton
Senior Program Administrator, Academic and Student Affairs
Healthcare Decision Analysis and Biopharmaceutical Marketing
南加大醫療決策分析碩士項目簡介
南加州大學藥學院的醫療決策分析碩士項目（MS in Healthcare Decision Analysis，簡稱HCDA）是全美首創的此類項目。
HCDA的課程設置兼具 “緊湊” 和 “跨領域”兩大特點，內容涵蓋專業的數據分析、國際化渠道及償付、產品估價及定價、醫保設計及運作。課程極具強有競爭力的商業視野，尤其適合畢業后志在醫藥醫療領域發展的學生，為日益多元化的醫藥醫療領域做準備。
HCDA項目適合已經擁有醫藥學和醫學專業學位的學生，和其他擁有應用科學、經濟學、商科等學業背景的本科生。
注冊：http://uscshanghai.mikecrm.com/UKcNZF7
外事處
2018-11-9